Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      AMN Healthcare Announces Third Quarter 2019 Results

      Quarterly revenue of $568 million;

      GAAP EPS of $0.49 and adjusted EPS of $0.81

      AMN Healthcare Logo. (PRNewsFoto/AMN Healthcare)

      News provided by

      AMN Healthcare Services, Inc.

      Oct 31, 2019, 16:15 ET

      Share this article

      Share this article


      DALLAS and SAN DIEGO, Oct. 31, 2019 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in healthcare workforce solutions and staffing services, today announced its third quarter 2019 financial results. Financial highlights are as follows:

      Dollars in millions, except per share amounts.



      Q3 2019

      % Change
      Q3 2018

      YTD
      September
      30, 2019

      % Change
      YTD 
      September
      30, 2018

      Revenue

      $567.6

      8%

      $1,635.2

      2%

      Gross profit

      $190.0

      8%

      $546.3

      4%

      Net income

      $23.5

      (16)%

      $86.5

      (18)%

      Diluted EPS

      $0.49

      (16)%

      $1.82

      (16)%

      Adjusted diluted EPS*

      $0.81

      (4)%

      $2.33

      (6)%

      Adjusted EBITDA*

      $69.3

      3%

      $202.0

      (1)%


      *  See "Non-GAAP Measures" below for a discussion of our use of non-GAAP items and the table entitled "Supplemental Financial and Operating Data" for a reconciliation of non-GAAP items.

      Highlights

      • Third quarter financial results above high end of Company guidance
      • Strong demand continues with Nurse and Allied orders at a three-year high, while a tight labor market limits near-term volume growth
      • Advanced Medical, our recently acquired allied and nursing staffing business, is performing well with double-digit year-over-year revenue growth
      • Generated $72 million of free cash flow in Q3, driven in part by a reduction in DSO
      • On October 1, closed on new 8-year, $300 million unsecured debt financing to recharge the Company's capacity for acquisitions and stock repurchases

      "A solid demand environment and sound execution by the AMN team enabled us to beat expectations for revenue and earnings in the third quarter.  As healthcare organizations increasingly seek total talent partners, we have been fortunate to expand and add progressive new clients. This gives us the opportunity to help clients optimize their workforce while also providing our candidates with even more attractive career opportunities," said Susan R. Salka, Chief Executive Officer of AMN Healthcare.

      "The need for healthcare talent and workforce solutions by our clients has accelerated as labor market conditions remain very constrained. To ensure we have access to the best talent possible for our clients, we are continuing to utilize innovative recruitment strategies, and we have the ability to further leverage our expanded recruitment team from the recent Advanced acquisition," Ms. Salka added.

      Third Quarter 2019 Results

      Consolidated revenue for the quarter was $568 million, an 8% increase over prior year and 6% higher than prior quarter. On an organic basis, consolidated revenue was up 1% over prior year. Revenue for the Nurse and Allied Solutions segment was $363 million, up 18% year over year (6% organic) and 9% sequentially. Travel Nurse division revenue grew 10% year over year with 4% organic growth. Allied division revenue increased 46% year over year, 11% organic.

      The Locum Tenens Solutions segment reported revenue of $84 million, down by 17% year over year but up 3% sequentially. Other Workforce Solutions segment revenue was $121 million for an increase of 1% year over year, driven by growth in our interim leadership and VMS businesses.

      Gross margin was 33.5%, higher by 30 basis points year over year and flat sequentially. The year-over-year variance was driven by improved gross margins in the Nurse and Allied and Other Workforce Solutions segments.

      SG&A expenses were $133 million, or 23.5% of revenue, compared with $121 million, or 23.0% of revenue, in the same quarter last year. SG&A was $122 million, or 22.7% of revenue, in the previous quarter. The year-over-year increase in SG&A costs came mainly from the recent acquisitions, a higher earn-out provision and higher employee-related expenses, partly offset by lower legal reserves.

      Income from operations was $40 million, or 7.0% of revenue, compared with $43 million, or 8.1% of revenue, in the same quarter last year. Adjusted EBITDA was $69 million, a year-over-year increase of 3%. Adjusted EBITDA margin was 12.2%, representing a decrease of 60 basis points year over year.

      Net income was $24 million, or $0.49 per diluted share, compared with $28 million, or $0.58 per diluted share, in the same quarter last year. Adjusted diluted EPS was $0.81.

      At September 30, 2019, cash and cash equivalents totaled $41 million. Cash flow from operations was $81 million for the quarter, and capital expenditures were $9 million. The Company ended the quarter with total debt outstanding of $620 million, with a leverage ratio as calculated in accordance with the Company's credit agreement of 2.2 to 1.

      October Debt Refinancing

      In October, AMN issued $300 million of 4.625% senior notes due in 2027 and used the proceeds to repay the Company's revolving debt and term loan, which totaled $295 million. After these actions, the Company had total debt of $625 million and unused borrowing capacity of $383 million on its senior credit facility.

      Fourth Quarter 2019 Outlook

      Metric

      Guidance*

      Consolidated revenue

      $573 - $579 million

      Gross margin

      33.5%

      SG&A as percentage of revenue

      22.5%

      Operating margin

      8.2%

      Adjusted EBITDA margin

      12.0%


      *Note: Guidance percentage metrics are approximate.  For a reconciliation of adjusted EBITDA margin to operating margin, see the table entitled "Reconciliation of Guidance Adjusted EBITDA Margin to Guidance Operating Margin" below.

      Revenue in the fourth quarter of 2019 is expected to be approximately 8-9% higher year over year. This guidance does not assume any material labor disruption revenue in the quarter.

      Conference Call on October 31, 2019

      AMN Healthcare Services, Inc. (NYSE: AMN), healthcare's leader and innovator in workforce solutions and staffing services, will host a conference call to discuss its third quarter 2019 financial results and outlook on Thursday, October 31, 2019, at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://amnhealthcare.investorroom.com/eventcalendar. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 288-8960 in the U.S. or (612) 234-9960 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company's website. Alternatively, a telephonic replay of the call will be available starting at 7:30 p.m. Eastern Time on October 31, 2019, and can be accessed until 11:59 p.m. Eastern Time on November 14, 2019, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 472944.

      About AMN Healthcare

      AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive labor analytics, revenue cycle solutions, credentialing solutions, and other services. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry.

      The Company's common stock is listed on the New York Stock Exchange under the symbol "AMN." For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication ("RSS") as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://amnhealthcare.investorroom.com/emailalerts.

      Non-GAAP Measures

      This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company's condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin and (3) adjusted diluted EPS.  The Company provides such non-GAAP financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company's operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP measures and may be different from non-GAAP measures, or may be calculated differently than other similarly titled non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company's performance.  A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled "Supplemental Financial and Operating Data" under the caption entitled "Reconciliation of Non-GAAP Items" and the footnotes thereto or on the Company's website at http://amnhealthcare.investorroom.com/financialreports. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company's website.

      Forward-Looking Statements

      This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our guidance for fourth quarter 2019 revenue, gross margin, SG&A expenses as a percentage of revenue and adjusted EBITDA margin, the accelerating need for healthcare talent and workforce solutions, and the labor shortage. The Company bases these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may," "estimates," variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.

      The Company's ability to meet the targets and expectations noted in our fourth quarter 2019 outlook depends upon, among other factors, our ability to  (i) manage the pricing impact that the consolidation of healthcare delivery organizations may have on our business, (ii) comply with extensive and complex federal and state laws and regulations related to the conduct of our operations, costs and payment for services and payment for referrals as well as laws regarding employment practices, (iii) implement new infrastructure and technology systems to optimize our operating results and manage our business effectively, (iv) develop and evolve our current technology offerings and capabilities, (v) recruit and retain sufficient quality healthcare professionals at reasonable costs, and (vi) consummate and effectively incorporate acquisitions into our business.

      For a discussion of additional risk factors and a more complete discussion of some of the cautionary statements noted above that could cause actual results to differ from those implied by the forward-looking statements contained in this press release, please refer to our most recent Annual Report on Form 10-K for the year ended December 31, 2018, our subsequent Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated and the Company is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.

      Contact:
      Randle Reece
      Director, Investor Relations
      866.861.3229

      AMN Healthcare Services, Inc.

      Condensed Consolidated Statements of Comprehensive Income

      (in thousands, except per share amounts)

      (unaudited)



      Three Months Ended


      Nine Months Ended


      September 30,


      June 30,


      September 30,


      2019


      2018


      2019


      2019


      2018

      Revenue

      $

      567,597


      $

      526,842


      $

      535,177


      $

      1,635,215


      $

      1,607,439

      Cost of revenue

      377,566


      351,695


      355,635


      1,088,883


      1,083,512

      Gross profit

      190,031


      175,147


      179,542


      546,332


      523,927

      Gross margin

      33.5%


      33.2%


      33.5%


      33.4%


      32.6%

      Operating expenses:










      Selling, general and administrative (SG&A)

      133,207


      121,216


      121,668


      374,872


      341,488

      SG&A as a % of revenue

      23.5%


      23.0%


      22.7%


      22.9%


      21.2%











      Depreciation and amortization

      17,085


      11,296


      12,718


      41,513


      29,788

      Total operating expenses

      150,292


      132,512


      134,386


      416,385


      371,276

      Income from operations

      39,739


      42,635


      45,156


      129,947


      152,651

      Operating margin (1)

      7.0%


      8.1%


      8.4%


      7.9%


      9.5%











      Interest expense, net, and other

      7,830


      4,649


      6,065


      19,568


      16,360











      Income before income taxes

      31,909


      37,986


      39,091


      110,379


      136,291











      Income tax expense

      8,394


      10,068


      10,222


      23,873


      30,163

      Net income

      $

      23,515


      $

      27,918


      $

      28,869


      $

      86,506


      $

      106,128

      Net income as a % of revenue

      4.1%


      5.3%


      5.4%


      5.3%


      6.6%











      Other comprehensive income (loss):










      Foreign currency translation and other

      132


      133


      (89)


      (58)


      205

      Other comprehensive income (loss)

      132


      133


      (89)


      (58)


      205











      Comprehensive income

      $

      23,647


      $

      28,051


      $

      28,780


      $

      86,448


      $

      106,333











      Net income per common share:










      Basic

      $

      0.50


      $

      0.59


      $

      0.62


      $

      1.85


      $

      2.23

      Diluted

      $

      0.49


      $

      0.58


      $

      0.61


      $

      1.82


      $

      2.17

      Weighted average common shares outstanding:










      Basic

      46,677


      47,286


      46,644


      46,701


      47,556

      Diluted

      47,607


      48,529


      47,424


      47,600


      48,859











      AMN Healthcare Services, Inc.

      Supplemental Financial and Operating Data

      (dollars in thousands, except per share data and operating data)

      (unaudited)



      Three Months Ended


      Nine Months Ended


      September 30,


      June 30,


      September 30,


      2019


      2018


      2019


      2019


      2018

      Revenue










      Nurse and allied solutions

      $

      362,533


      $

      306,292


      $

      331,627


      $

      1,031,189


      $

      977,199

      Locum tenens solutions

      84,164


      101,102


      82,074


      246,728


      311,516

      Other workforce solutions

      120,900


      119,448


      121,476


      357,298


      318,724


      $

      567,597


      $

      526,842


      $

      535,177


      $

      1,635,215


      $

      1,607,439











      Reconciliation of Non-GAAP Items:




















      Segment operating income (2)










      Nurse and allied solutions

      $

      47,544


      $

      42,165


      $

      48,694


      $

      144,160


      $

      137,906

      Locum tenens solutions

      6,156


      10,992


      7,128


      18,985


      34,321

      Other workforce solutions

      27,806


      29,010


      27,127


      81,121


      77,437


      81,506


      82,167


      82,949


      244,266


      249,664

      Unallocated corporate overhead

      12,255


      14,739


      16,217


      42,306


      45,657

      Adjusted EBITDA (3)

      69,251


      67,428


      66,732


      201,960


      204,007

      Adjusted EBITDA margin (4)

      12.2%


      12.8%


      12.5%


      12.4%


      12.7%











      Depreciation and amortization

      17,085


      11,296


      12,718


      41,513


      29,788

      Share-based compensation (5)

      2,825


      1,809


      3,702


      11,713


      7,954

      Acquisition, integration, and other costs (6)

      9,602


      (452)


      5,156


      18,787


      1,474

      Legal settlement accrual increases (7)

      —


      12,140


      —


      —


      12,140

      Income from operations

      39,739


      42,635


      45,156


      129,947


      152,651

      Interest expense, net, and other

      7,830


      4,649


      6,065


      19,568


      16,360

      Income before income taxes

      31,909


      37,986


      39,091


      110,379


      136,291

      Income tax expense

      8,394


      10,068


      10,222


      23,873


      30,163

      Net income

      $

      23,515


      $

      27,918


      $

      28,869


      $

      86,506


      $

      106,128











      GAAP diluted net income per share (EPS)

      $

      0.49


      $

      0.58


      $

      0.61


      $

      1.82


      $

      2.17

      Adjustments:










      Amortization of intangible assets

      0.24


      0.14


      0.15


      0.53


      0.36

      Acquisition, integration, and other costs (6)

      0.20


      (0.01)


      0.11


      0.40


      0.03

      Legal settlement accrual increases (7)

      —


      0.25


      —


      —


      0.25

      Equity investment fair value changes (8)

      —


      (0.03)


      —


      —


      (0.03)

      Debt financing related costs

      —


      —


      —


      —


      0.01

      Tax effect on above adjustments

      (0.11)


      (0.09)


      (0.07)


      (0.24)


      (0.16)

      Tax correction related to prior periods (9)

      —


      —


      —


      —


      (0.05)

      Tax effect of COLI fair value changes (10)

      —


      —


      (0.01)


      (0.05)


      —

      Excess tax benefits (11)

      (0.01)


      —


      (0.02)


      (0.13)


      (0.11)

      Adjusted diluted EPS (12)

      $

      0.81


      $

      0.84


      $

      0.77


      $

      2.33


      $

      2.47












      Three Months Ended


      Nine Months Ended


      September 30,


      June 30,


      September 30,


      2019


      2018


      2019


      2019


      2018

      Gross Margin










      Nurse and allied solutions

      27.9%


      27.4%


      27.5%


      27.8%


      27.2%

      Locum tenens solutions

      27.5%


      28.4%


      27.8%


      27.7%


      29.0%

      Other workforce solutions

      54.3%


      52.4%


      54.0%


      53.7%


      52.6%





















      Operating Data:










      Nurse and allied solutions










      Average healthcare

      professionals on assignment (13)

      10,294


      8,979


      9,393


      9,756


      9,214











      Locum tenens solutions










      Days filled (14)

      42,700


      50,069


      41,563


      124,759


      158,089

      Revenue per day filled (15)

      $

      1,971


      $

      2,019


      $

      1,975


      $

      1,978


      $

      1,971
































      As of September 30,


      As of June 30,


      2019


      2018


      2019

      Leverage ratio (16)

      2.2


      1.7


      2.4







      AMN Healthcare Services, Inc.

      Condensed Consolidated Balance Sheets

      (dollars in thousands)

      (unaudited)



      September 30,
      2019


      December 31,
      2018


      September 30,
      2018

      Assets






      Current assets:






      Cash and cash equivalents

      $

      40,748



      $

      13,856



      $

      18,614


      Accounts receivable, net

      354,742



      365,871



      366,436


      Accounts receivable, subcontractor

      62,752



      50,143



      44,891


      Prepaid and other current assets

      48,690



      52,296



      49,898


      Total current assets

      506,932



      482,166



      479,839


      Restricted cash, cash equivalents and investments

      59,165



      59,331



      59,453


      Fixed assets, net

      100,199



      90,419



      86,817


      Operating lease right-of-use assets

      92,257



      —



      —


      Other assets

      115,482



      96,152



      93,206


      Goodwill

      586,611



      438,506



      438,299


      Intangible assets, net

      400,428



      326,147



      332,788


      Total assets

      $

      1,861,074



      $

      1,492,721



      $

      1,490,402








      Liabilities and stockholders' equity






      Current liabilities:






      Accounts payable and accrued expenses

      $

      139,505



      $

      149,603



      $

      142,543


      Accrued compensation and benefits

      157,950



      135,059



      135,632


      Current portion of notes payable

      3,750



      —



      —


      Current portion of operating lease liabilities

      13,387



      —



      —


      Deferred revenue

      11,227



      12,365



      13,107


      Other current liabilities

      18,090



      10,243



      11,806


      Total current liabilities

      343,909



      307,270



      303,088


      Revolving credit facility

      146,000



      120,000



      150,000


      Notes payable, less unamortized fees

      465,899



      320,607



      320,416


      Deferred income taxes, net

      46,356



      27,326



      24,651


      Operating lease liabilities

      94,150



      —



      —


      Other long-term liabilities

      59,656



      78,528



      77,527


      Total liabilities

      1,155,970



      853,731



      875,682








      Commitments and contingencies












      Stockholders' equity:

      705,104



      638,990



      614,720








      Total liabilities and stockholders' equity

      $

      1,861,074



      $

      1,492,721



      $

      1,490,402


      AMN Healthcare Services, Inc.

      Summary Condensed Consolidated Statements of Cash Flows

      (dollars in thousands)

      (unaudited)



      Three Months Ended


      Nine Months Ended


      September 30,


      June 30,


      September 30,


      2019


      2018


      2019


      2019


      2018









      Net cash provided by operating activities

      $

      80,914



      $

      42,108



      $

      29,077



      $

      146,205



      $

      168,046


      Net cash used in investing activities

      (12,915)



      (32,698)



      (204,443)



      (253,606)



      (271,648)


      Net cash provided by (used in) financing activities

      (52,845)



      (36,883)



      187,495



      136,440



      81,774


      Effect of exchange rates on cash

      132



      133



      (89)



      (58)



      205


      Net increase (decrease) in cash, cash equivalents and restricted cash

      15,286



      (27,340)



      12,040



      28,981



      (21,623)


      Cash, cash equivalents and restricted cash at beginning of period

      98,019



      104,611



      85,979



      84,324



      98,894


      Cash, cash equivalents and restricted cash at end of period

      $

      113,305



      $

      77,271



      $

      98,019



      $

      113,305



      $

      77,271


      AMN Healthcare Services, Inc.

      Additional Supplemental Non-GAAP Disclosures

      Reconciliation of Guidance Adjusted EBITDA Margin to

      Guidance Operating Margin

      (unaudited)



      Three Months Ended


      December 31, 2019



      Adjusted EBITDA margin (17)

      12.0%

      Deduct:


      Share-based compensation

      0.6%

      Acquisition, integration and other costs

      0.2%

      EBITDA margin

      11.2%

      Depreciation and amortization

      3.0%

      Operating margin

      8.2%

      (1)

      Operating margin represents income from operations divided by revenue.

      (2)

      Segment operating income represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, unallocated corporate overhead, acquisition and integration costs, extraordinary legal expenses, legal settlement accrual increases and share-based compensation.

      (3)

      Adjusted EBITDA represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, acquisition and integration costs, extraordinary legal expenses, legal settlement accrual increases and share-based compensation. Management believes that adjusted EBITDA provides an effective measure of the Company's results, as it excludes certain items that management believes are not indicative of the Company's operating performance and is a measure used in the Company's credit agreement and the indentures governing our 5.125% Senior Notes due 2024 and our 4.625% Senior Notes due 2027. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income.

      (4)

      Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.

      (5)

      Share-based compensation for the nine months ended September 30, 2019 was impacted by two modifications during the first quarter and effective in 2019, a new vesting condition that resulted in accelerated expense recognition.

      (6)

      Acquisition, integration, and other costs of $9,602,000 and $18,787,000 for the three and nine months ended September 30, 2019, respectively, include net increases in the fair  value of contingent consideration liabilities for recently acquired companies of $4,441,000 and $2,283,000, respectively, and extraordinary legal expenses of approximately $2,100,000 and $6,700,000, respectively. Beginning in 2019, we exclude the impact of extraordinary legal expenses from the calculation of adjusted EBITDA because we believe that these expenses are not indicative of the Company's operating performance.

      (7)

      During the third quarter of 2018, the Company recorded increases to its legal accruals established in connection with settlement agreements entered into during September and October 2018 in two class actions related to wage and hour claims, both of which were paid during 2019. For the three months ended September 30, 2018, the increases amounted to $12,140,000. Since the settlements are largely unrelated to the Company's operating performance, we excluded the impact on adjusted EBITDA and adjusted diluted EPS for the three months ended September 30, 2018. Amounts recorded in prior quarters in these two class actions and legal accruals related to other matters are immaterial and their impact was not excluded from adjusted EBITDA or adjusted diluted EPS.

      (8)

      As a result of the adoption of a new accounting pronouncement on January 1, 2018, the Company now measures equity investments, except those accounted for using the equity method of accounting, at fair value with changes in fair value recognized through net income. For the three and nine months ended September 30, 2018, changes in fair value of equity investments recognized in interest expense, net, and other were $1,359,000. Since this favorable change in fair value is unrelated to the Company's operating performance, we excluded the impact on adjusted diluted EPS for the three and nine months ended September 30, 2018.

      (9)

      During the first quarter of 2018, the Company recorded a net tax benefit of $2,501,000 to adjust for an immaterial out-of-period error identified in that quarter related to the income tax treatment of fair value changes in the cash surrender value of its company owned life insurance for years ended December 31, 2015 through December 31, 2017. These fair value changes had not previously been included as a benefit in the tax provision of the related years.

      (10)

      The Company recorded a net tax benefit of $162,000 and $2,264,000 related to the income tax treatment of the fair value changes in the cash surrender value of its company owned life insurance for the three and nine months ended September 30, 2019, respectively. Since these changes in fair value are unrelated to the Company's operating performance, we exclude the impact on adjusted diluted EPS.

      (11)

      The consolidated effective tax rate for the three and nine months ended September 30, 2019 was favorably affected by the recording of excess tax benefits relating to equity awards vested and exercised during the period. As a result of the adoption of a new accounting pronouncement on January 1, 2017, we no longer record excess tax benefits as an increase to additional paid-in capital, but record such excess tax benefits on a prospective basis as a reduction of income tax expense, which amounted to $576,000 and $5,000 for the three months ended September 30, 2019 and 2018, respectively. For the nine months ended September 30, 2019 and 2018, excess tax benefits recorded as a reduction of income tax expense were $6,118,000 and $5,099,000, respectively. The magnitude of the impact of excess tax benefits generated in the future, which may be favorable or unfavorable, is dependent upon the Company's future grants of share-based compensation, the Company's future stock price on the date awards vest or exercise in relation to the fair value of the awards on the grant date or the exercise behavior of the Company's stock appreciation rights holders. Since these favorable tax benefits are largely unrelated to our current year's income before taxes and is unrepresentative of our normal effective tax rate, we exclude their impact on adjusted diluted EPS.

      (12)

      Adjusted diluted EPS represents GAAP diluted EPS excluding the impact of the (A) amortization of intangible assets, (B) acquisition and integration costs, (C) extraordinary legal expenses, (D) legal settlement accrual increases, (E) changes in fair value of equity investments since January 1, 2018, (F) deferred financing costs, (G) tax effect, if any, of the foregoing adjustments, (H) excess tax benefits relating to equity awards vested and exercised since January 1, 2017, and (I) correction of prior periods error. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company's operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded from adjusted diluted EPS). Although management believes the items excluded from adjusted diluted EPS are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.

      (13)

      Average healthcare professionals on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented. Excluding Advanced Medical, which was acquired during the second quarter of 2019, the average healthcare professionals on assignment was 9,125 and 9,307 for the three and nine months ended September 30, 2019, respectively.

      (14)

      Days filled is calculated by dividing the locum tenens hours filled during the period by eight hours.

      (15)

      Revenue per day filled represents revenue of the Company's locum tenens solutions segment divided by days filled for the period presented.

      (16)

      Leverage ratio represents the ratio of the consolidated funded indebtedness (as calculated per the Company's credit   agreement) at the end of the subject period to the consolidated adjusted EBITDA (as calculated per the Company's credit agreement) for the twelve-month period ended at the end of the subject period.

      (17)

      Guidance percentage metrics are approximate.

      SOURCE AMN Healthcare Services, Inc.

      Modal title

      Also from this source

      AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2026 RESULTS

      AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2026 RESULTS

      AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States,...

      Gastroenterologists Overtake Orthopedic Surgeons as Highest-Paid Physician Recruits, AMN Healthcare Report Finds

      Gastroenterologists Overtake Orthopedic Surgeons as Highest-Paid Physician Recruits, AMN Healthcare Report Finds

      Gastroenterologists are now offered the highest average starting salary of any physician, at $654,000, according to AMN Healthcare's annual review of ...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Human Resource & Workforce Management

      Human Resource & Workforce Management

      Earnings

      Earnings

      Conference Call Announcements

      Conference Call Announcements

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.